» Articles » PMID: 26624979

Molecular Pathway Activation Features Linked with Transition from Normal Skin to Primary and Metastatic Melanomas in Human

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Dec 2
PMID 26624979
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Melanoma is the most aggressive and dangerous type of skin cancer, but its molecular mechanisms remain largely unclear. For transcriptomic data of 478 primary and metastatic melanoma, nevi and normal skin samples, we performed high-throughput analysis of intracellular molecular networks including 592 signaling and metabolic pathways. We showed that at the molecular pathway level, the formation of nevi largely resembles transition from normal skin to primary melanoma. Using a combination of bioinformatic machine learning algorithms, we identified 44 characteristic signaling and metabolic pathways connected with the formation of nevi, development of primary melanoma, and its metastases. We created a model describing formation and progression of melanoma at the level of molecular pathway activation. We discovered six novel associations between activation of metabolic molecular pathways and progression of melanoma: for allopregnanolone biosynthesis, L-carnitine biosynthesis, zymosterol biosynthesis (inhibited in melanoma), fructose 2, 6-bisphosphate synthesis and dephosphorylation, resolvin D biosynthesis (activated in melanoma), D-myo-inositol hexakisphosphate biosynthesis (activated in primary, inhibited in metastatic melanoma). Finally, we discovered fourteen tightly coordinated functional clusters of molecular pathways. This study helps to decode molecular mechanisms underlying the development of melanoma.

Citing Articles

Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives.

Tajbakhsh A, Yousefi F, Farahani N, Savardashtaki A, Reiner Z, Jamialahmadi T Curr Med Chem. 2023; 31(36):5898-5917.

PMID: 37497711 DOI: 10.2174/0929867331666230727100123.


Integration of lncRNAs, Protein-Coding Genes and Pathology Images for Detecting Metastatic Melanoma.

Liu S, Fan Y, Li K, Zhang H, Wang X, Ju R Genes (Basel). 2022; 13(10).

PMID: 36292801 PMC: 9602061. DOI: 10.3390/genes13101916.


Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review.

Ma E, Hoegler K, Zhou A Genes (Basel). 2021; 12(11).

PMID: 34828357 PMC: 8621295. DOI: 10.3390/genes12111751.


Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context.

Ershov P, Kaluzhskiy L, Mezentsev Y, Yablokov E, Gnedenko O, Ivanov A Biomedicines. 2021; 9(8).

PMID: 34440098 PMC: 8389681. DOI: 10.3390/biomedicines9080895.


The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy.

Lazar A, Dinescu S, Costache M Cancers (Basel). 2020; 12(11).

PMID: 33203119 PMC: 7696690. DOI: 10.3390/cancers12113378.


References
1.
Niu X, Zhang T, Liao L, Zhou L, Lindner D, Zhou M . The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene. 2011; 31(6):776-86. PMC: 4238297. DOI: 10.1038/onc.2011.266. View

2.
Jerant A, Johnson J, Sheridan C, Caffrey T . Early detection and treatment of skin cancer. Am Fam Physician. 2000; 62(2):357-68, 375-6, 381-2. View

3.
Lee K, Chuang E, Griffin M, Khattri R, Hong D, Zhang W . Molecular basis of T cell inactivation by CTLA-4. Science. 1998; 282(5397):2263-6. DOI: 10.1126/science.282.5397.2263. View

4.
Makarev E, Cantor C, Zhavoronkov A, Buzdin A, Aliper A, Csoka A . Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions. Aging (Albany NY). 2014; 6(12):1064-75. PMC: 4298366. DOI: 10.18632/aging.100711. View

5.
El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V . A review of human carcinogens--part D: radiation. Lancet Oncol. 2009; 10(8):751-2. DOI: 10.1016/s1470-2045(09)70213-x. View